Synchron
Campbell, US · Delaware corporation · 8 known investors
Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline. The company serves patients with motor impairment and cognitive decline using a minimally invasive approach inspired by cardiac interventional procedures.
Founders & leadership
TJ
Thomas James OxleyExecutive Officer, Director
MD
Martin DieckDirector
NO
Nicholas OpieDirector
RS
Rahul SharmaDirector
AM
Alex MorganDirector
Investors · 8
ARCH Venture PartnersChicago · $50K – $250M
Forepont Capital PartnersNew York
ID8 InvestmentsNew Yorkvia Mussadiq Lakhani · inferred
Kaleida CapitalSan Diegovia Ariane Tom · led
Khosla VenturesMenlo Park · $5K – $50Mvia Alex Morgan · board
Bezos Expeditionsreported
In-Q-TelreportedTysons · $100K – $2.5M
re.Mind CapitalreportedLondon
Reported raises · per SEC filings
Form D private placements▶$72.3MraisedDec 2022 · 22 investors · OtherRule 506(b)
▶$72.3MraisedDec 2022 · 22 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Alex MorganDirector
- Rahul SharmaDirector
- Thomas James OxleyExecutive Officer, Director
- Ari NowacekDirector
- Martin DieckDirector
- Nicholas OpieDirector
- Offering amount
- $86M
- Amount sold
- $72.3M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$32.6MraisedMay 2021 · 14 investors · OtherRule 506(b)
▶$32.6MraisedMay 2021 · 14 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Thomas James OxleyExecutive Officer, Director
- Martin DieckDirector
- Nicholas OpieDirector
- Rahul SharmaDirector
- Alex MorganDirector
- Offering amount
- $38.9M
- Amount sold
- $32.6M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Synchron raises $200M to prepare for brain computer interface launch | MedTech Divemedtechdive.com · 2025
- Synchron Raises $200M in Series D Fundingfinsmes.com · 2025
- Synchron raises $200M Series D to support BCI commercialization, next-gen techmassdevice.com · 2025
- Synchron Raises $200 Million Series D to Advance Brain-Computer Interface Technologybusinesswire.com · 2025
- Sell or Invest in Synchron Stock Pre-IPOnasdaqprivatemarket.com · 2025
- Synchron Raises $75M Series C to Advance Endovascular Brain-Computer Interfacebusinesswire.com · 2022
- Bezos and Gates Back Synchron in Drive for Brain Implant Breakthroughbloomberg.com · 2022
- Max Hodak – Investing in Synchronmaxhodak.com · 2022

